Early Warning ScoreNCT07051421
RECOVERY ROOM EARLY WARNING SCORE
An observational study of Early Warning Score, run by Istinye University.
Trial summary
In this study, we aimed to develop a scoring system that facilitates patient risk stratification in the recovery room during the postanesthetic follow-up period and can objectively identify patients in need of early intervention. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Early Warning Score
- What is being tested?
- EARLY WARNING SCORE
- Type of treatment
- Surgery or procedure
- How many people
- 208 participants
- Where
- No sites listed yet
- Study dates
- 1 Jul 2025to 1 Dec 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients over 18 years of age, in ASA class I-III, who have undergone planned elective surgery under general anesthesia, and who have been informed and given informed consent in advance of the study.
Who may be able to join
- Those over 18 years of age,
- Those in ASA I-III class,
- Those who have undergone planned elective surgery under general anesthesia,
- Those who have been informed about the study in advance and given their consent.
Who cannot join
- Those under 18 years of age,
- Those who underwent emergency intervention,
- Those in the ASA-Ⅳ class,
- Those who underwent regional anesthesia,
- Those with a history of cognitive retardation, visual-hearing impairment or psychiatric disease that prevents communication, those who have previously been diagnosed with neurocognitive disorders,
- Patients who could not complete the procedure, patients with data loss,
- Patients whose general anesthesia duration is less than 90 minutes will not be included in the study.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: A NEW EARLY WARNING SCORE TO SUPPORT CLINICAL DECISION PROCESSES IN POSTANESTHETIC FOLLOW-UP: RECO-EWS
In this study, we aimed to develop a scoring system that facilitates patient risk stratification in the recovery room during the postanesthetic follow-up period and can objectively identify patients in need of early intervention.
- Conditions
- Early Warning Score
- Being tested
- EARLY WARNING SCORE
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EARLY WARNING SCOREProcedure or surgery
In the RECO-EWS scoring system we designed; 0-7 low risk, 7-10 medium risk, ≥10 high risk, postoperative stay findings of high-risk patients and, if necessary, new cut-off values are determined for each parameter in the scoring system according to the analysis results.
What is being measured
The primary outcome is the main question the study is designed to answer.
RECO-EWS
0-7 low risk, 7-10 medium risk, ≥10 high risk
Measured: 24 HOURS
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Jul 2025
- Study start1 Jul 2025 (estimated)
- Primary completion1 Nov 2025 (estimated)
- Study completion1 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Early Warning ScoreStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 208 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Istinye University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, İlke Dolgun, Haseki Training and Research Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07051421
- Sponsor's protocol ID
- HASEKI AHMET TEZ
- Status last verified
- Jun 2025
- First submitted
- 26 Jun 2025
- Last updated
- 4 Jul 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Pazar B, Yava A. Evaluation of Early Warning Scoring System and Nursing Guide Application in Post-Anaesthesia Care Unit. Turk J Anaesthesiol Reanim. 2013 Dec;41(6):216-22. doi: 10.5152/TJAR.2013.37. Epub 2013 May 23.
PubMed 27366375Mert S, Kersu O, Cesur S, Topbas O, Erdogan S. The Effect of Modified Early Warning Score (MEWS) and Nursing Guide Application on Postoperative Patient Outcomes: A Randomized Controlled Study. J Perianesth Nurs. 2024 Aug;39(4):596-603. doi: 10.1016/j.jopan.2023.10.023. Epub 2024 Feb 1.
PubMed 38300197
Study at a glance
From the registry record, last updated by the sponsor on 4 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A NEW EARLY WARNING SCORE TO SUPPORT CLINICAL DECISION PROCESSES IN POSTANESTHETIC FOLLOW-UP: RECO-EWS
- ClinicalTrials.gov ID
- NCT07051421
- Acronym / sponsor ID
- HASEKI AHMET TEZ
- Conditions
- Early Warning Score
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 208 participants (estimated)
- Lead sponsor
- Istinye UniversityUniversity, hospital or other
- Study start
- 1 Jul 2025 (estimated)
- Primary completion
- 1 Nov 2025 (estimated)
- Study completion
- 1 Dec 2025 (estimated)
- First posted
- 4 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study, we aimed to develop a scoring system that facilitates patient risk stratification in the recovery room during the postanesthetic follow-up period and can objectively identify patients in need of early intervention.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients over 18 years of age, in ASA class I-III, who have undergone planned elective surgery under general anesthesia, and who have been informed and given informed consent in advance of the study.
Key inclusion criteria (4 listed)
- Those over 18 years of age,
- Those in ASA I-III class,
- Those who have undergone planned elective surgery under general anesthesia,
- Those who have been informed about the study in advance and given their consent.
Key exclusion criteria (7 listed)
- Those under 18 years of age,
- Those who underwent emergency intervention,
- Those in the ASA-Ⅳ class,
- Those who underwent regional anesthesia,
- Those with a history of cognitive retardation, visual-hearing impairment or psychiatric disease that prevents communication, those who have previously been diagnosed with neurocognitive disorders,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EARLY WARNING SCOREIn the RECO-EWS scoring system we designed; 0-7 low risk, 7-10 medium risk, ≥10 high risk, postoperative stay findings of high-risk patients and, if necessary, new cut-off values are determined for each parameter in the scoring system according to the analysis results. | Procedure or surgery | – |
Primary outcome
RECO-EWS
Time frame: 24 HOURS
0-7 low risk, 7-10 medium risk, ≥10 high risk
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Jul 2025.
- Results publication: PubMed 27366375Pazar B, Yava A. Evaluation of Early Warning Scoring System and Nursing Guide Application in Post-Anaesthesia Care Unit. Turk J Anaesthesiol Reanim. 2013 Dec;41(6):216-22. doi: 10.5152/TJAR.2013.37. Epub 2013 May 23.
- Results publication: PubMed 38300197Mert S, Kersu O, Cesur S, Topbas O, Erdogan S. The Effect of Modified Early Warning Score (MEWS) and Nursing Guide Application on Postoperative Patient Outcomes: A Randomized Controlled Study. J Perianesth Nurs. 2024 Aug;39(4):596-603. doi: 10.1016/j.jopan.2023.10.023. Epub 2024 Feb 1.
- Individual participant dataSharing planned: No
Related trials for Early Warning Score
Not yet recruiting
Hospital-Onset Sepsis Systematic Detection and Structured Interventions
Sepsis, Deterioration, Clinical
Recruiting
Rapid Response Teams - How and Who?
Hospital Rapid Response Team, Early Warning Score
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Early Warning Score, run by Istinye University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 4 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact ILKE DOLGUN (+905555485632, ilkeser2004@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
RECO-EWS (time frame: 24 HOURS). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07051421, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jul 2025; AzTrials last refreshed its copy on 30 Oct 2026.